The Russian medical equipment developer Palekh Engineering has integrated artificial intelligence into the first domestically produced implantable cardioverter-defibrillator (ICD). Testing of the AI-based software suite has been launched, GxP News was told by the company.
An ICD continuously monitors a patient’s heart rhythm and delivers an electrical shock to correct life-threatening arrhythmias when detected. The AI integrated into the device analyzes arrhythmia episodes and identifies possible malfunctions in the device’s operation. The system will allow cardiologists to analyze and adjust a patient’s device.
The developers explained that the new ICD system will also track long-term changes in the patient’s condition and inform the doctor in advance about any negative and positive trends. Based on the ICD’s operation history for a specific patient, the AI will be able to suggest optimal Anti-Tachycardia Pacing (ATP) settings to the doctor.
“Our goal is not to replace the cardiologist, but to provide them with the most modern digital tool for saving lives, and ultimately to create a full-fledged domestic device of world-class standard,” emphasized Sergey Korolev, one of the company’s product developers.
The first domestic ICD was created in March of this year. Leading specialists from Russia’s largest clinics participated in the device’s creation: the Federal Scientific and Clinical Center of FMBA of Russia and the Moscow Regional Research and Clinical Institute named after M.F. Vladimirsky. 292.5 million rubles were invested in the development. The company estimates the volume of additional investment needed at 1 billion rubles.
